{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:25:37Z","timestamp":1786119937308,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/aci.0b013e3283489c2c","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T05:48:14Z","timestamp":1307512094000},"page":"292-298","source":"Crossref","is-referenced-by-count":15,"title":["The innate immune system in delayed cutaneous allergic reactions to medications"],"prefix":"10.1097","volume":"11","author":[{"given":"Teresa","family":"Bell\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Blanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"S548","DOI":"10.1067\/mai.2003.93","article-title":"Drug allergy.","volume":"111","author":"Gruchalla","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions.","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann Intern Med"},{"key":"R3-5-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity.","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.coi.2004.09.016","article-title":"Cellular mechanisms of T cell mediated drug hypersensitivity.","volume":"16","author":"Gerber","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tox.2004.12.014","article-title":"Direct T-cell stimulations by drugs-bypassing the innate immune system.","volume":"209","author":"Pichler","year":"2005","journal-title":"Toxicology"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family.","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.it.2006.06.003","article-title":"TLRs, NLRs and RLRs. A trinity of pathogen sensors that co-operate in innate immunity.","volume":"27","author":"Creagh","year":"2006","journal-title":"Trends Immunol"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02256.x","article-title":"Putting the natural killer cell in its place.","volume":"117","author":"OConnor","year":"2006","journal-title":"Immunology"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.1000889","article-title":"Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism.","volume":"185","author":"Elsheikh","year":"2010","journal-title":"J Immunol"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2006.07.013","article-title":"Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams.","volume":"118","author":"Rodriguez-Pena","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R11-5-20210128","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/jpet.109.155374","article-title":"Danger conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells.","volume":"331","author":"Lavergne","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-5-20210128","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaci.2010.06.004","article-title":"Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome.","volume":"126","author":"Sugita","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1590\/S0100-879X2010007500096","article-title":"Functional changes of dendritic cells in hypersensivity reactions to amoxicillin.","volume":"43","author":"Lima","year":"2010","journal-title":"Braz J Med Biol Res"},{"key":"R14-5-20210128","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1365-2133.2009.09627.x","article-title":"Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases.","volume":"162","author":"Bellon","year":"2010","journal-title":"Br J Dermatol"},{"key":"R15-5-20210128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00403-004-0506-z","article-title":"Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome.","volume":"296","author":"Gaultier","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"R16-5-20210128","doi-asserted-by":"crossref","first-page":"37258","DOI":"10.1074\/jbc.M106089200","article-title":"The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase BMMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.","volume":"276","author":"Yan","year":"2001","journal-title":"J Biol Chem"},{"key":"R17-5-20210128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1067\/mjd.2002.120473","article-title":"Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis.","volume":"47","author":"Correia","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R18-5-20210128","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis.","volume":"123","author":"Nassif","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.165.5.2783","article-title":"Proinflammatory effects of IL-10 during human endotoxemia.","volume":"165","author":"Lauw","year":"2000","journal-title":"J Immunol"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0625.2010.01176.x","article-title":"Death ligand TRAIL, secreted by CD1a and CD14 cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis.","volume":"20","author":"de Araujo","year":"2011","journal-title":"Exp Dermatol"},{"key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000284592","article-title":"Functionally active macrophage-derived myeloperoxidase in the skin of drug-induced toxic epidermal necrolysis.","volume":"220","author":"Paquet","year":"2010","journal-title":"Dermatology"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2009.09280.x","article-title":"Emergence of circulating monomyeloid precursors predicts reactivation of human herpesvirus-6 in drug-induced hypersensitivity syndrome.","volume":"161","author":"Hashizume","year":"2009","journal-title":"Br J Dermatol"},{"key":"R23-5-20210128","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","article-title":"Alarmins: chemotactic activators of immune responses.","volume":"17","author":"Oppenheim","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"R25-5-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: all we need to know about danger.","volume":"81","author":"Bianchi","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0560.1999.tb01848.x","article-title":"Epidermal calprotectin in drug-induced toxic epidermal necrolysis.","volume":"26","author":"Paquet","year":"1999","journal-title":"J Cutan Pathol"},{"key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.4049\/jimmunol.173.10.6134","article-title":"Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation.","volume":"173","author":"Yang","year":"2004","journal-title":"J Immunol"},{"key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.20062027","article-title":"Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses.","volume":"205","author":"Yang","year":"2008","journal-title":"J Exp Med"},{"key":"R29-5-20210128","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nri1180","article-title":"Defensins: antimicrobial peptides of innate immunity.","volume":"3","author":"Ganz","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R30-5-20210128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00062752-200701000-00005","article-title":"Multispecific myeloid defensins.","volume":"14","author":"Lehrer","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1398-9995.2010.02484.x","article-title":"Expression of alpha-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions.","volume":"66","author":"Morel","year":"2011","journal-title":"Allergy"},{"key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaci.2009.10.030","article-title":"CD94NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"125","author":"Morel","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R34-5-20210128","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"R35-5-20210128","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1182\/blood-2010-03-273953","article-title":"Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin.","volume":"116","author":"Tewary","year":"2010","journal-title":"Blood"},{"key":"R36-5-20210128","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/eji.200323977","article-title":"Granulysin in human serum as a marker of cell-mediated immunity.","volume":"33","author":"Ogawa","year":"2003","journal-title":"Eur J Immunol"},{"key":"R37-5-20210128","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","article-title":"Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome.","volume":"151","author":"Abe","year":"2009","journal-title":"Ann Intern Med"},{"key":"R38-5-20210128","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets.","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"R39-5-20210128","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1398-9995.2010.02459.x","article-title":"Natural killer-dendritic cell interaction in lymphocyte responses in hypersensitivity reactions to betalactams.","volume":"65","author":"Chaves","year":"2010","journal-title":"Allergy"},{"key":"R40-5-20210128","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1398-9995.2009.02180.x","article-title":"In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases.","volume":"65","author":"Zawodniak","year":"2010","journal-title":"Allergy"},{"key":"R41-5-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0952-7915(99)80048-X","article-title":"Bellon T: natural killer cell activation and inhibition by receptors for MHC class I.","volume":"11","author":"Lopez-Botet","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"R42-5-20210128","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/eji.200425843","article-title":"The CD94NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8 T cells.","volume":"35","author":"Guma","year":"2005","journal-title":"Eur J Immunol"},{"key":"R43-5-20210128","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.20060028","article-title":"Reprogramming of CTLs into natural killer-like cells in celiac disease.","volume":"203","author":"Meresse","year":"2006","journal-title":"J Exp Med"},{"key":"R44-5-20210128","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.4049\/jimmunol.1003409","article-title":"Granulysin delivered by cytotoxic cells damages endoplasmic reticulum and activates caspase-7 in target cells.","volume":"186","author":"Saini","year":"2011","journal-title":"J Immunol"},{"key":"R45-5-20210128","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/eji.1830250432","article-title":"Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a nongranule pathway.","volume":"25","author":"Isaaz","year":"1995","journal-title":"Eur J Immunol"},{"key":"R46-5-20210128","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1371\/journal.pone.0000326","article-title":"Serial killing of tumor cells by human natural killer cells-enhancement by therapeutic antibodies.","volume":"2","author":"Bhat","year":"2007","journal-title":"PLoS One"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ACI.0b013e3283489c2c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:32:28Z","timestamp":1786044748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130832-201108000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e3283489c2c","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}